| Stage | NDAQ | % of rev | MSTR | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $2.4B | 100.00% | $125M | 100.00% | NDAQ ×19.08 |
| Gross profit | $1.1B | 46.05% | $90M | 71.46% | MSTR +25.4pp |
| Operating income | $732M | 30.59% | $20.9B | 16670.89% | MSTR +16640.3pp |
| Pre-tax income | $701M | 29.29% | $20.9B | 16696.79% | MSTR +16667.5pp |
| Net income | $539M | 22.52% | $19.5B | 15573.18% | MSTR +15550.7pp |
| Stage | NDAQ | MSTR | Gap · A − B |
|---|---|---|---|
| Revenue | $2.4B100.00% | $125M100.00% | NDAQ ×19.08 |
| Gross profit | 46.05%$1.1B | 71.46%$90M | MSTR +25.4pp |
| Operating income | 30.59%$732M | 16670.89%$20.9B | MSTR +16640.3pp |
| Pre-tax income | 29.29%$701M | 16696.79%$20.9B | MSTR +16667.5pp |
| Net income | 22.52%$539M | 15573.18%$19.5B | MSTR +15550.7pp |
No shared counterparties.